snac in semaglutide Peptide of the Week: Peptide: A Promising Advancement Diabetes Treatment A new era for oral

Recent hypotheses suggest that GIP induces appetite suppression through independent receptors in the brain, mitigates gastrointestinal side effects of GLP-1 action, and prevents desensitization of GLP-1 receptors, thereby acting as a biased GLP-1RA [87]

The gastrointestinal (GI) tract is commonly affected in both type 1 and type 2 diabetes, leading to increased morbidity and healthcare costs, and often presents a diagnostic and therapeutic challenge

Abstract Background Cognitive function can be affected in conditions with raised intracranial pressure (ICP) such as idiopathic intracranial hypertension (IIH)

Johansen PB, et al

orphan-drug status is not an approval